Skip to main content
Equibles

FMR LLC

Position in ANIP — Ani Pharmaceuticals Inc

CIK 315066 BOSTON, MA
Back to ANIP Full portfolio

Position in ANIP

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$3,050,276
+$1,606,326 QoQ
Shares Held
36,848
+96.2% QoQ
Ownership
0.160%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#88
of 305 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in ANIP Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

FMR LLC holds $7,214,215,829 across 49 Drug Manufacturers - Specialty & Generic names. ANIP ranks #27 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VTRS
Viatris Inc
 96,662,102 $1,534,994,177
2 ELAN
Elanco Animal Health Inc
 56,948,819 $1,401,510,433
3 HLN
Haleon plc
 120,991,250 $1,128,848,360
4 TEVA
Teva Pharmaceutical Industries Ltd
 30,258,016 $1,025,141,579
5 KNSA
Kiniksa Pharmaceuticals International, plc
 6,971,361 $445,818,534
6 LNTH
Lantheus Holdings, Inc.
 3,879,971 $430,443,982
7 AMLX
Amylyx Pharmaceuticals, Inc.
 16,727,909 $300,433,243
8 UTHR
UNITED THERAPEUTICS Corp
 473,409 $256,507,196

All Filings in ANIP

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,050,276 36,848
2026-03-31 $1,443,950 18,777
2025-12-31 $778,110 9,857
2025-09-30 $3,214,610 35,094
2025-06-30 $237,183 3,635
2025-03-31 $239,412 3,576
2024-12-31 $170,869 3,091
2024-09-30 $1,097,803 18,401
2024-06-30 $918,837 14,429
2024-03-31 $37,606 544
2023-12-31 $27,238 494
2023-09-30 $28,507 491
2023-06-30 $24,546 456
2023-03-31 $11,717 295
2022-12-31 $11,344 282
2022-09-30 $11,377 354
2022-06-30 $2,610 88
2022-03-31 $3,851 137
2021-06-30 $420 12
2020-12-31 $7,143 246
2020-09-30 $7,700 273
2020-06-30 $7,955 246
2020-03-31 $10,022 246